Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Prediction of survival in amyotrophic lateral sclerosis: a nationwide, Danish cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Blastic plasmacytoid dendritic cell neoplasm and cerebral toxoplasmosis: a case report

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The association of selected multiple sclerosis symptoms with disability and quality of life: a large Danish self-report survey

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Severe hypersomnia after unilateral infarction in the pulvinar nucleus- a case report

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Normal pressure hydrocephalus secondary to Lyme disease, a case report and review of seven reported cases

    Research output: Contribution to journalReviewResearchpeer-review

  1. Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Clinical trials in pediatric ALS: a TRICALS feasibility study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Diagnostic and prognostic performance of Mxa and transfer function analysis-based dynamic cerebral autoregulation metrics

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Vancomycin-resistant Enterococcus faecium: should we screen on admission?

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Endurance Training Improves GLP-1 Sensitivity and Glucose Tolerance in Overweight Women

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

INTRODUCTION: Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease with great heterogeneity. Biological prognostic markers are needed for the patients to plan future supportive treatment, palliative treatment, and end-of-life decisions. In addition, prognostic markers are greatly needed for the randomization in clinical trials.

OBJECTIVE: This study aimed to test the ALS Functional Rating Scale-Revised (ALSFRS-R) progression rate (ΔFS) as a prognostic marker of survival in a Danish ALS cohort.

METHODS: The ALSFRS-R score at test date in association with duration of symptoms, from the onset of symptoms until test date, (defined as ΔFS') was calculated for 90 Danish patients diagnosed with either probable or definite sporadic ALS. Median survival time was then estimated from the onset of symptoms until primary endpoint (either death or tracheostomy). ΔFS' was subjected to survival analysis using Cox proportional hazards modelling, log-rank test, and Kaplan-Meier survival analysis.

RESULTS AND CONCLUSIONS: Both ΔFS' and age was found to be strong predictors of survival of the Danish ALS cohort. Both variables are easily obtained at the time of diagnosis and could be used by clinicians and ALS patients to plan future supportive and palliative treatment. Furthermore, ΔFS', is a simple, prognostic marker that predicts survival in the early phase of disease as well as at later stages of the disease.

Original languageEnglish
Article number164
JournalBMC Neurology
Volume21
Issue number1
Pages (from-to)164
ISSN1471-2377
DOIs
Publication statusPublished - Dec 2021

    Research areas

  • Adult, Aged, Amyotrophic Lateral Sclerosis/mortality, Cohort Studies, Denmark, Disease Progression, Female, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Prognosis, Severity of Illness Index, Amyotrophic lateral sclerosis, ALSFRS-R slope, Median survival time, Prognostic biomarker

ID: 66256963